BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
19.10.12 Zurich Insurance neutral Sarasin Research
19.10.12 Holcim hold Deutsche Bank AG
19.10.12 Novartis outperform Exane-BNP Paribas SA
19.10.12 Zurich Insurance hold Deutsche Bank AG
19.10.12 Nestlé outperform Exane-BNP Paribas SA
19.10.12 Holcim neutral J.P. Morgan Cazenove
19.10.12 Swiss Re neutral Sarasin Research
19.10.12 ABB (Asea Brown Boveri) neutral Nomura
19.10.12 Zurich Insurance neutral Exane-BNP Paribas SA
19.10.12 Holcim overweight J.P. Morgan Cazenove
19.10.12 Nestlé hold Vontobel Research
19.10.12 Swiss Re buy Vontobel Research
18.10.12 Roche outperform Credit Suisse Group
18.10.12 Zurich Insurance neutral Credit Suisse Group
18.10.12 ABB (Asea Brown Boveri) buy Citigroup Corp.
18.10.12 UBS overweight Morgan Stanley
18.10.12 UBS equal-weight Morgan Stanley
18.10.12 Julius Bär equal-weight Morgan Stanley
18.10.12 Swiss Life buy Nomura
18.10.12 Givaudan sell Goldman Sachs Group Inc.
18.10.12 Roche overweight J.P. Morgan Cazenove
18.10.12 Nestlé buy Sarasin Research
18.10.12 Givaudan outperform Exane-BNP Paribas SA
18.10.12 UBS buy Deutsche Bank AG
18.10.12 UBS hold Deutsche Bank AG
18.10.12 Straumann hold Vontobel Research
18.10.12 Nestlé outperform Cheuvreux SA
18.10.12 Nestlé hold Vontobel Research
18.10.12 Zurich Insurance hold Société Générale Group S.A. (SG)
18.10.12 ABB (Asea Brown Boveri) buy Vontobel Research
18.10.12 Roche halten Hamburger Sparkasse AG (Haspa)
18.10.12 Zurich Insurance outperform Keefe, Bruyette & Woods, Inc.
17.10.12 Givaudan overweight J.P. Morgan Cazenove
17.10.12 Zurich Insurance halten Independent Research GmbH
17.10.12 Roche outperform Exane-BNP Paribas SA
17.10.12 Novartis reduce Vontobel Research
17.10.12 Givaudan hold Vontobel Research
17.10.12 Novartis outperform Exane-BNP Paribas SA
17.10.12 Zurich Insurance neutral Sarasin Research
17.10.12 Zurich Insurance hold Vontobel Research